Citations (116)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (4)
Akira Taguchi, Masataka Shiraki, Toshitsugu Sugimoto, Hiroaki Ohta & Satoshi Soen. (2016) Lack of cooperation between physicians and dentists during osteoporosis treatment may increase fractures and osteonecrosis of the jaw. Current Medical Research and Opinion 32:7, pages 1261-1268.
Read now
Read now
Evangelos Terpos, James Berenson, Noopur Raje & G David Roodman. (2014) Management of bone disease in multiple myeloma. Expert Review of Hematology 7:1, pages 113-125.
Read now
Read now
Morie A. Gertz. (2011) The role of bisphosphonate therapy in the global management of multiple myeloma. Leukemia & Lymphoma 52:5, pages 736-737.
Read now
Read now
Dimitrios Christoulas, Evangelos Terpos & Meletios A Dimopoulos. (2009) Pathogenesis and management of myeloma bone disease. Expert Review of Hematology 2:4, pages 385-398.
Read now
Read now
Articles from other publishers (112)
Martin Johansen, Mette Bøegh Levring, Kasper Stokbro, Marta Diaz-delCastillo, Abdul Ahad Khan, Line Adsbøll Wickstroem, Michael Tveden Gundesen, Ida Bruun Kristensen, Charlotte Guldborg Nyvold, Mikkel Østerheden Andersen, Thomas Levin Andersen, Niels Abildgaard & Thomas Lund. (2023) Novel Developments in the Treatment of Multiple Myeloma-Associated Bone Disease. Cancers 15:23, pages 5585.
Crossref
Crossref
Emily Sunny Lee, Meng-Chen Tsai, Jing-Xuan Lee, Chuki Wong, You-Ning Cheng, An-Chi Liu, You-Fang Liang, Chih-Yuan Fang, Chia-Yu Wu & I-Ta Lee. (2023) Bisphosphonates and Their Connection to Dental Procedures: Exploring Bisphosphonate-Related Osteonecrosis of the Jaws. Cancers 15:22, pages 5366.
Crossref
Crossref
Diana Nogueira, Inês Morais Caldas & Ricardo Jorge Dinis-Oliveira. (2023) Bisphosphonates and osteonecrosis of the jaws: Clinical and forensic aspects. Archives of Oral Biology 155, pages 105792.
Crossref
Crossref
Antonio Ciardo, Marlinde M. Simon, Sinclair Awounvo & Ti-Sun Kim. (2023) Oral health conditions in patients under antiresorptive therapy are comparable to unexposed during supportive periodontal care. Clinical Oral Investigations 27:11, pages 6523-6536.
Crossref
Crossref
Oliver Ristow, Thomas Rückschloß, Gregor Schnug, Julius Moratin, Moritz Bleymehl, Sven Zittel, Maximilian Pilz, Caroline Sekundo, Christian Mertens, Michael Engel, Jürgen Hoffmann & Maximilian Smielowski. (2023) Comparison of Different Antibiotic Regimes for Preventive Tooth Extractions in Patients with Antiresorptive Intake—A Retrospective Cohort Study. Antibiotics 12:6, pages 997.
Crossref
Crossref
Ruxandra Coropciuc, Renaat Coopman, Melisa Garip, Evelien Gielen, Constantinus Politis, Tim Van den Wyngaert & Benoit Beuselinck. (2023) Risk of medication-related osteonecrosis of the jaw after dental extractions in patients receiving antiresorptive agents — A retrospective study of 240 patients. Bone 170, pages 116722.
Crossref
Crossref
Robin Kasper, Mario Scheurer, Sebastian Pietzka, Andreas Sakkas, Alexander Schramm, Frank Wilde & Marcel Ebeling. (2023) MRONJ of the Mandible—From Decortication to a Complex Jaw Reconstruction Using a CAD/CAM-Guided Bilateral Scapula Flap. Medicina 59:3, pages 535.
Crossref
Crossref
Chang Liu, Yu-Tao Xiong, Tao Zhu, Wei Liu, Wei Tang & Wei Zeng. (2022) Management of Tooth Extraction in Patients Taking Antiresorptive Drugs: An Evidence Mapping Review and Meta-Analysis. Journal of Clinical Medicine 12:1, pages 239.
Crossref
Crossref
Salvatore L. Ruggiero, Thomas B. Dodson, Tara Aghaloo, Eric R. Carlson, Brent B. Ward & Deepak Kademani. (2022) American Association of Oral and Maxillofacial Surgeons’ Position Paper on Medication-Related Osteonecrosis of the Jaws—2022 Update. Journal of Oral and Maxillofacial Surgery 80:5, pages 920-943.
Crossref
Crossref
Athanasios D Anastasilakis, Jessica Pepe, Nicola Napoli, Andrea Palermo, Christos Magopoulos, Aliya A Khan, M Carola Zillikens & Jean-Jacques Body. (2022) Osteonecrosis of the Jaw and Antiresorptive Agents in Benign and Malignant Diseases: A Critical Review Organized by the ECTS. The Journal of Clinical Endocrinology & Metabolism 107:5, pages 1441-1460.
Crossref
Crossref
Donald B. Kimmel. 2022. Osteoporotic Fracture and Systemic Skeletal Disorders. Osteoporotic Fracture and Systemic Skeletal Disorders
317
338
.
J.I. Aguirre, E.J. Castillo & D.B. Kimmel. (2021) Preclinical models of medication-related osteonecrosis of the jaw (MRONJ). Bone 153, pages 116184.
Crossref
Crossref
Simra Azher & Amish Patel. (2021) Antibiotics in Dentoalveolar Surgery, a Closer Look at Infection, Alveolar Osteitis and Adverse Drug Reaction. Journal of Oral and Maxillofacial Surgery 79:11, pages 2203-2214.
Crossref
Crossref
Roberto Pippi, Umberto Giuliani, Gianluca Tenore, Alessandra Pietrantoni & Umberto Romeo. (2021) What is the Risk of Developing Medication-Related Osteonecrosis in Patients With Extraction Sockets Left to Heal by Secondary Intention? A Retrospective Case Series Study. Journal of Oral and Maxillofacial Surgery 79:10, pages 2071-2077.
Crossref
Crossref
Evangelos Terpos & Ioannis Ntanasis‐Stathopoulos. (2020) Controversies in the use of new bone‐modifying therapies in multiple myeloma. British Journal of Haematology 193:6, pages 1034-1043.
Crossref
Crossref
Florian Ewald, Falk Wuesthoff, Robert Koehnke, Reinhard E. Friedrich, Martin Gosau, Ralf Smeets, Holger Rohde & Alexandre T. Assaf. (2020) Retrospective analysis of bacterial colonization of necrotic bone and antibiotic resistance in 98 patients with medication-related osteonecrosis of the jaw (MRONJ). Clinical Oral Investigations 25:5, pages 2801-2809.
Crossref
Crossref
Ioannis PapadakisAlexandra SpanouDemos Kalyvas. (2021) Success Rate and Safety of Dental Implantology in Patients Treated With Antiresorptive Medication: A Systematic Review. Journal of Oral Implantology 47:2, pages 169-180.
Crossref
Crossref
Evangelos Terpos, Elena Zamagni, Suzanne Lentzsch, Matthew T Drake, Ramón García-Sanz, Niels Abildgaard, Ioannis Ntanasis-Stathopoulos, Fredrik Schjesvold, Javier de la Rubia, Charalampia Kyriakou, Jens Hillengass, Sonja Zweegman, Michele Cavo, Philippe Moreau, Jesus San-Miguel, Meletios A Dimopoulos, Nikhil Munshi, Brian G M Durie & Noopur Raje. (2021) Treatment of multiple myeloma-related bone disease: recommendations from the Bone Working Group of the International Myeloma Working Group. The Lancet Oncology 22:3, pages e119-e130.
Crossref
Crossref
Marco Cabras, Alessio Gambino, Roberto Broccoletti, Savino Sciascia & Paolo G. Arduino. (2021) Lack of evidence in reducing risk of MRONJ after teeth extractions with systemic antibiotics. Journal of Oral Science 63:3, pages 217-226.
Crossref
Crossref
Claire Lainé, Aline Desoutter & Anne-Gaëlle Chaux. (2021) Clinical attitude regarding denosumab drug-holiday for dental extraction in oncologic patients: a national survey. Journal of Oral Medicine and Oral Surgery 27:3, pages 38.
Crossref
Crossref
Ahmad Oryan & Sonia Sahvieh. (2021) Effects of bisphosphonates on osteoporosis: Focus on zoledronate. Life Sciences 264, pages 118681.
Crossref
Crossref
Louise Dunphy, Giovanni Salzano, Barbara Gerber & Jennifer Graystone. (2020) Republished: Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. Drug and Therapeutics Bulletin 58:11, pages 172-175.
Crossref
Crossref
Stine Rasch, Thomas Lund, Jon Thor Asmussen, Anne Lerberg Nielsen, Rikke Faebo Larsen, Mikkel Østerheden Andersen & Niels Abildgaard. (2020) Multiple Myeloma Associated Bone Disease. Cancers 12:8, pages 2113.
Crossref
Crossref
Philipp Poxleitner, David Steybe, Philipp Kroneberg, Michael Andreas Ermer, Gül Merve Yalcin-Ülker, Rainer Schmelzeisen & Pit Jacob Voss. (2020) Tooth extractions in patients under antiresorptive therapy for osteoporosis: Primary closure of the extraction socket with a mucoperiosteal flap versus application of platelet-rich fibrin for the prevention of antiresorptive agent-related osteonecrosis of the jaw. Journal of Cranio-Maxillofacial Surgery 48:4, pages 444-451.
Crossref
Crossref
Louise Dunphy, Giovanni Salzano, Barbara Gerber & Jennifer Graystone. (2020) Medication-related osteonecrosis (MRONJ) of the mandible and maxilla. BMJ Case Reports 13:1, pages e224455.
Crossref
Crossref
Noam Yarom, Charles L. Shapiro, Douglas E. Peterson, Catherine H. Van Poznak, Kari Bohlke, Salvatore L. Ruggiero, Cesar A. Migliorati, Aliya Khan, Archie Morrison, Holly Anderson, Barbara A. Murphy, Devena Alston-Johnson, Rui Amaral Mendes, Beth Michelle Beadle, Siri Beier Jensen & Deborah P. Saunders. (2019) Medication-Related Osteonecrosis of the Jaw: MASCC/ISOO/ASCO Clinical Practice Guideline. Journal of Clinical Oncology 37:25, pages 2270-2290.
Crossref
Crossref
Akishige Hokugo, Keiichi Kanayama, Shuting Sun, Kenzo Morinaga, Yujie Sun, QingQing Wu, Hodaka Sasaki, Hiroko Okawa, Courtney Evans, Frank H. Ebetino, Mark W. Lundy, Keivan Sadrerafi, Charles E. McKenna & Ichiro Nishimura. (2019) Rescue bisphosphonate treatment of alveolar bone improves extraction socket healing and reduces osteonecrosis in zoledronate-treated mice. Bone 123, pages 115-128.
Crossref
Crossref
Jonathan G. Messer, Jessica M. Jiron, Jorge L. Mendieta Calle, Evelyn J. Castillo, Ronnie Israel, Ean G. Phillips, Joshua F. Yarrow, Catherine Van Poznak, Lakshmyya Kesavalu, Donald B. Kimmel & J. Ignacio Aguirre. (2019) Zoledronate treatment duration is linked to bisphosphonate‐related osteonecrosis of the jaw prevalence in rice rats with generalized periodontitis. Oral Diseases 25:4, pages 1116-1135.
Crossref
Crossref
Muhammad Asad Fraz, Faiza Hassan Warraich, Sami Ullah Warraich, Muhammad Junaid Tariq, Zabih Warraich, Ali Younas Khan, Muhammad Usman, Awais Ijaz, Pavan Tenneti, Adeela Mushtaq, Faisal Akbar, Zaina Shahid, Zeeshan Ali, Hafiz Muhammad Fazeel, Cesar Rodriguez, Aboo Nasar, Ali McBride & Faiz Anwer. (2019) Special considerations for the treatment of multiple myeloma according to advanced age, comorbidities, frailty and organ dysfunction. Critical Reviews in Oncology/Hematology 137, pages 18-26.
Crossref
Crossref
Flávia Aparecida Cariolatto, Julia Carelli, Taís de Campos Moreira, Ricardo Pietrobon, Clarissa Rodrigues & Ana Paula Bonilauri Ferreira. (2018) Recommendations for the Prevention of Bisphosphonate-Related Osteonecrosis of the Jaw: A Systematic Review. Journal of Evidence Based Dental Practice 18:2, pages 142-152.
Crossref
Crossref
Evangelos Terpos, Dimitrios Christoulas & Maria Gavriatopoulou. (2018) Biology and treatment of myeloma related bone disease. Metabolism 80, pages 80-90.
Crossref
Crossref
J. J. Segura‐Egea, K. Gould, B. Hakan Şen, P. Jonasson, E. Cotti, A. Mazzoni, H. Sunay, L. Tjäderhane & P. M. H. Dummer. (2017) European Society of Endodontology position statement: the use of antibiotics in endodontics. International Endodontic Journal 51:1, pages 20-25.
Crossref
Crossref
V. Patel, J. Mansi, S. Ghosh, J. Kwok, M. Burke, D. Reilly, N. Nizarali, C. Sproat & K. Chia. (2017) MRONJ risk of adjuvant bisphosphonates in early stage breast cancer. British Dental Journal 224:2, pages 74-79.
Crossref
Crossref
Jerusha Santa Packyanathan, C. Elizabeth Rani Juneius & M. Vinoth. 2018. Microbial Biotechnology. Microbial Biotechnology
515
533
.
Evangelos Terpos & Nikolaos Kanellias. 2018. Personalized Therapy for Multiple Myeloma. Personalized Therapy for Multiple Myeloma
131
167
.
Evangelos Terpos, Nikolaos Kanellias & Noopur Raje. 2018. Multiple Myeloma and Other Plasma Cell Neoplasms. Multiple Myeloma and Other Plasma Cell Neoplasms
111
140
.
J. J. Segura-Egea, K. Gould, B. Hakan Şen, P. Jonasson, E. Cotti, A. Mazzoni, H. Sunay, L. Tjäderhane & P. M. H. Dummer. (2017) Antibiotics in Endodontics: a review. International Endodontic Journal 50:12, pages 1169-1184.
Crossref
Crossref
Nils Heim, Felix Benjamin Warwas, Christian Timm Wilms, Rudolf H. Reich & Markus Martini. (2017) Vitamin D (25-OHD) deficiency may increase the prevalence of medication-related osteonecrosis of the jaw. Journal of Cranio-Maxillofacial Surgery 45:12, pages 2068-2074.
Crossref
Crossref
. (2017) AAE Position Statement. Journal of Endodontics 43:9, pages 1409-1413.
Crossref
Crossref
Oi Lin Lee, Noemi Horvath, Cindy Lee, Doug Joshua, Joy Ho, Jeff Szer, Hang Quach, Andrew Spencer, Simon Harrison, Peter Mollee, Andrew W. Roberts, Dipti Talaulikar, Ross Brown, Bradley Augustson, Silvia Ling, Wilfrid Jaksic, John Gibson, Anna Kalff, Anna Johnston, Akash Kalro, Chris Ward, H. Miles Prince & Andrew Zannettino. (2017) Bisphosphonate guidelines for treatment and prevention of myeloma bone disease. Internal Medicine Journal 47:8, pages 938-951.
Crossref
Crossref
Kenji Yamagata, Fumihiko Uchida, Naomi Kanno, Toru Yanagawa & Hiroki Bukawa. 2017. Osteonecrosis. Osteonecrosis.
Sung Ok Hong, Chae-Yoon Lee, Junho Jung, Deog-Yoon Kim, Christian Walter & Yong-Dae Kwon. (2016) A retrospective study of osteomyelitis and osteonecrosis of the jaws and its etiologic implication of bisphosphonate in Asians. Clinical Oral Investigations 21:5, pages 1905-1911.
Crossref
Crossref
Philipp Poxleitner, Monika Engelhardt, Rainer Schmelzeisen & Pit Voss. (2017) The Prevention of Medication-related Osteonecrosis of the Jaw. Deutsches Ärzteblatt international.
Crossref
Crossref
Aliya A. Khan, Archie Morrison, David L. Kendler, Rene Rizzoli, David A. Hanley, Dieter Felsenberg, Laurie K. McCauley, Felice O'Ryan, Ian R. Reid, Salvatore L. Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B. Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M. Cheung, Suzanne N. Morin, Basel Masri, Cyrus Cooper, Sarah L. Morgan, Barbara Obermayer-Pietsch, Bente L. Langdahl, Rana Al Dabagh, K. Shawn Davison, George K. Sándor, Robert G. Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D. Pierroz, Riad Sulimani, Deborah P. Saunders, Jacques P. Brown & Juliet Compston. (2017) Case-Based Review of Osteonecrosis of the Jaw (ONJ) and Application of the International Recommendations for Management From the International Task Force on ONJ. Journal of Clinical Densitometry 20:1, pages 8-24.
Crossref
Crossref
Christian Walter, Bilal Al-Nawas, Tim Wolff, Eik Schiegnitz & Knut A. Gr?tz. (2016) Dental implants in patients treated with antiresorptive medication ? a systematic literature review. International Journal of Implant Dentistry 2:1.
Crossref
Crossref
PG de Barros Silva, CC de Oliveira, LAC Brizeno, DVT Wong, RCP Lima Júnior, RP Gonçalves, FB Sousa, MRL Mota, R de Albuquerque Ribeiro & APNN Alves. (2016) Immune cellular profile of bisphosphonate-related osteonecrosis of the jaw. Oral Diseases 22:7, pages 649-657.
Crossref
Crossref
Petra Rugani, Christian Walter, Barbara Kirnbauer, Stephan Acham, Yvonne Begus-Nahrman & Norbert Jakse. (2016) Prevalence of Medication-Related Osteonecrosis of the Jaw in Patients with Breast Cancer, Prostate Cancer, and Multiple Myeloma. Dentistry Journal 4:4, pages 32.
Crossref
Crossref
Carla I. Ripamonti, Maurizio Lucchesi & Raffaele Giusti. (2016) Prevention and management of osteonecrosis of the jaw secondary to bone-targeted therapy in patients with kidney cancer. Current Opinion in Supportive & Palliative Care 10:3, pages 273-280.
Crossref
Crossref
K. A. Grötz & B. Al-Nawas. (2016) Antiresorptiva-assoziierte KiefernekroseAntiresorptive-associated osteonecrosis of the jaw. Der MKG-Chirurg 9:3, pages 207-217.
Crossref
Crossref
Shirin Kalyan, Jun Wang, Elgar Susanne Quabius, Jörn Huck, Jörg Wiltfang, John F Baines & Dieter Kabelitz. (2015) Systemic immunity shapes the oral microbiome and susceptibility to bisphosphonate-associated osteonecrosis of the jaw. Journal of Translational Medicine 13:1.
Crossref
Crossref
Neha P Shah, Helen Katsarelis, Michael Pazianas & Daljit K Dhariwal. (2015) Periodontal disease, dental implants, extractions and medications related to osteonecrosis of the jaws. Dental Update 42:9, pages 878-889.
Crossref
Crossref
Reginald H. Goodday. (2015) Preventive Strategies for Patients at Risk of Medication-related Osteonecrosis of the Jaw. Oral and Maxillofacial Surgery Clinics of North America 27:4, pages 527-536.
Crossref
Crossref
Michelle C de Souza & Gabriela Stepavoi. (2015) Case report: beware the silver nitrate stick – a risk factor for bisphosphonate-related osteonecrosis of the jaw (BRONJ). Dental Update 42:8, pages 735-743.
Crossref
Crossref
Oliver Ristow, Sven Otto, Matthias Troeltzsch, Bettina Hohlweg-Majert & Christoph Pautke. (2015) Treatment perspectives for medication-related osteonecrosis of the jaw (MRONJ). Journal of Cranio-Maxillofacial Surgery 43:2, pages 290-293.
Crossref
Crossref
J.-J. Body. (2015) Traitements inhibiteurs de la r?sorption osseuse en situation m?tastatique : bilan actuel et perspectivesInhibitors of bone resorption for the treatment of bone metastases: Current status and perspectives. Oncologie 17:3, pages 117-126.
Crossref
Crossref
Christoph Pautke. 2015. Medication-Related Osteonecrosis of the Jaws. Medication-Related Osteonecrosis of the Jaws
79
91
.
Vera Hirsh. 2015. New Therapeutic Strategies in Lung Cancers. New Therapeutic Strategies in Lung Cancers
225
244
.
Aliya A Khan, Archie Morrison, David A Hanley, Dieter Felsenberg, Laurie K McCauley, Felice O'Ryan, Ian R Reid, Salvatore L Ruggiero, Akira Taguchi, Sotirios Tetradis, Nelson B Watts, Maria Luisa Brandi, Edmund Peters, Teresa Guise, Richard Eastell, Angela M Cheung, Suzanne N Morin, Basel Masri, Cyrus Cooper, Sarah L Morgan, Barbara Obermayer-Pietsch, Bente L Langdahl, Rana Al Dabagh, K. Shawn Davison, David L Kendler, George K Sándor, Robert G Josse, Mohit Bhandari, Mohamed El Rabbany, Dominique D Pierroz, Riad Sulimani, Deborah P Saunders, Jacques P Brown & Juliet Compston. (2015) Diagnosis and Management of Osteonecrosis of the Jaw: A Systematic Review and International Consensus. Journal of Bone and Mineral Research 30:1, pages 3-23.
Crossref
Crossref
Christian Walter, Keyvan Sagheb, Jennifer Bitzer, Roman Rahimi-Nedjat & Katherine Joyce Taylor. (2014) Analysis of reasons for osteonecrosis of the jaws. Clinical Oral Investigations 18:9, pages 2221-2226.
Crossref
Crossref
J. Karbach & B. Al-Nawas. (2014) Perioperative Antibiotikaprophylaxe in der MKG-ChirurgiePerioperative antibiotic prophylaxis in oral and maxillofacial surgery. Der MKG-Chirurg 7:4, pages 261-267.
Crossref
Crossref
Kenneth E. Fleisher, Roy A. Raad, Rajan Rakheja, Vikas Gupta, King Chong Chan, Kent P. Friedman, Karen A. Mourtzikos, Malvin Janal & Robert S. Glickman. (2014) Fluorodeoxyglucose Positron Emission Tomography With Computed Tomography Detects Greater Metabolic Changes That Are Not Represented by Plain Radiography for Patients With Osteonecrosis of the Jaw. Journal of Oral and Maxillofacial Surgery 72:10, pages 1957-1965.
Crossref
Crossref
Tamara Rordorf, Azza Adel Hassan, Hamdy Azim, Eniu Alexandru, Ozlem Er, Erhan Gokmen, Zeynep Güral, Jozef Mardiak, Velko Minchev, Florentia Peintinger, Miklos Szendroi, Itzok Takac, Petra Tesarova, Daniel Vorobiof, Damir Vrbanec, Ramazan Yildiz, Serap Yücel, Jamal Zekri & Basak Oyan. (2014) Bone health in breast cancer patients: A comprehensive statement by CECOG/SAKK Intergroup. The Breast 23:5, pages 511-525.
Crossref
Crossref
Graham H. Jackson, Gareth J. Morgan, Faith E. Davies, Ping Wu, Walter M. Gregory, Sue E. Bell, Alexander J. Szubert, Nuria Navarro Coy, Mark T. Drayson, Roger G. Owen, Sylvia Feyler, Andrew J. Ashcroft, Fiona M. Ross, Jennifer Byrne, Huw Roddie, Claudius Rudin, Kevin D. Boyd, Wendy L. Osborne, Gordon Cook & J. Anthony Child. (2014) Osteonecrosis of the jaw and renal safety in patients with newly diagnosed multiple myeloma: Medical Research Council Myeloma IX Study results. British Journal of Haematology 166:1, pages 109-117.
Crossref
Crossref
Marcus J. Heufelder, Joerg Hendricks, Torsten Remmerbach, Bernhard Frerich, Alexander Hemprich & Frank Wilde. (2014) Principles of oral surgery for prevention of bisphosphonate-related osteonecrosis of the jaw. Oral Surgery, Oral Medicine, Oral Pathology and Oral Radiology 117:6, pages e429-e435.
Crossref
Crossref
Evangelos Terpos, Nikolaos Kanellias & Krzysztof Giannopoulos. (2014) Biology and management of myeloma-related bone disease. Acta Haematologica Polonica 45:2, pages 107-121.
Crossref
Crossref
Vivek Thumbigere-Math, Bryan S. Michalowicz, James S. Hodges, Michaela L. Tsai, Karen K. Swenson, Laura Rockwell & Rajaram Gopalakrishnan. (2014) Periodontal Disease as a Risk Factor for Bisphosphonate-Related Osteonecrosis of the Jaw. Journal of Periodontology 85:2, pages 226-233.
Crossref
Crossref
Sebastian Hoefert & Siegmar Reinert. 2014. Knochenmetastasen. Knochenmetastasen
117
126
.
Matthew T. Drake. 2014. Multiple Myeloma. Multiple Myeloma
211
223
.
Francis Buadi & Asher Chanan Khan. 2014. Multiple Myeloma. Multiple Myeloma
159
177
.
G. Campisi, O. Di Fede, A. Bedogni, P. Vescovi, V. Fusco & L. Lo Muzio. (2013) Osteonecrosi dei mascellari associata a bisfosfonati, denosumab e farmaci anti-angiogenetici nei pazienti oncologici e osteoporotici: prevenzione dentale e sicurezza dei trattamenti odontoiatrici. Dental Cadmos 81:10, pages 634-649.
Crossref
Crossref
Kanchan M. Ganda. 2013. Dentist's Guide to Medical Conditions, Medications, and Complications. Dentist's Guide to Medical Conditions, Medications, and Complications
699
741
.
Jean‐Jacques Body. 2013. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism
741
753
.
Evangelos TerposGareth MorganMeletios A. DimopoulosMatthew T. DrakeSuzanne LentzschNoopur RajeOrhan SezerRamón García-SanzKazuyuki ShimizuIngemar TuressonTony ReimanArtur JurczyszynGiampaolo MerliniAndrew SpencerXavier LeleuMichele CavoNikhil MunshiS. Vincent RajkumarBrian G.M. DurieG. David Roodman. (2013) International Myeloma Working Group Recommendations for the Treatment of Multiple Myeloma–Related Bone Disease. Journal of Clinical Oncology 31:18, pages 2347-2357.
Crossref
Crossref
Richard Oliver & Mohamed Badr. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Steven J. Sadowsky & Edmond Bedrossian. (2013) Evidenced-Based Criteria for Differential Treatment Planning of Implant Restorations for the Partially Edentulous Patient. Journal of Prosthodontics 22:4, pages 319-329.
Crossref
Crossref
Iryna Kuchuk, Sasha Mazzarello, Kevin Butterfield, Anthony Appleton, Christina L. Addison & Mark Clemons. (2013) Oral care and the use of bone-targeted agents in patients with metastatic cancers: A practical guide for dental surgeons and oncologists. Journal of Bone Oncology 2:1, pages 38-46.
Crossref
Crossref
J. Karbach & B. Al-Nawas. (2013) Antiseptische und antiinfektive Prophylaxe in der Zahnmedizin. wissen kompakt 7:1, pages 23-32.
Crossref
Crossref
Patrizia Tosi. (2013) Diagnosis and Treatment of Bone Disease in Multiple Myeloma: Spotlight on Spinal Involvement. Scientifica 2013, pages 1-12.
Crossref
Crossref
Sil Park & Ichiro Nishimura. 2013. Oral and Cranial Implants. Oral and Cranial Implants
61
76
.
Ami Smidt, Mordekhai Lipovetsky-Adler & Eldad Sharon. (2012) Forced eruption as an alternative to tooth extraction in long-term use of oral bisphosphonates. The Journal of the American Dental Association 143:12, pages 1303-1312.
Crossref
Crossref
Evangelos Terpos, Efstathios Kastritis & Meletios A. Dimopoulos. (2012) Prevention and Treatment of Myeloma Bone Disease. Current Hematologic Malignancy Reports 7:4, pages 249-257.
Crossref
Crossref
Sebastian Kühl, Christian Walter, Stephan Acham, Roland Pfeffer & J. Thomas Lambrecht. (2012) Bisphosphonate-related osteonecrosis of the jaws – A review. Oral Oncology 48:10, pages 938-947.
Crossref
Crossref
C. Walter & B. Al-Nawas. (2012) Implantation bei Patienten unter oraler Bisphosphonattherapie aufgrund einer Osteoporose. wissen kompakt 6:3, pages 43-52.
Crossref
Crossref
Julia S. Bauer, Nina Beck, Julia Kiefer, Philipp Stockmann, Manfred Wichmann & Stephan Eitner. (2012) Awareness and education of patients receiving bisphosphonates. Journal of Cranio-Maxillofacial Surgery 40:3, pages 277-282.
Crossref
Crossref
Gerrard Teoh, Yuming Chen, Kihyun Kim, Alok Srivastava, Vasant R. Pai, Sung-Soo Yoon, Cheolwon Suh & Yeo-Kyeoung Kim. (2012) Lower Dose Dexamethasone/Thalidomide and Zoledronic Acid Every 3 Weeks in Previously Untreated Multiple Myeloma. Clinical Lymphoma Myeloma and Leukemia 12:2, pages 118-126.
Crossref
Crossref
A Andriani, M T Petrucci, T Caravita, M Montanaro, N Villivà, A Levi, A Siniscalchi, V Bongarzoni, F Pisani, M De Muro, U Coppetelli, G Avvisati, A Zullo, A Agrillo & D Gaglioti. (2012) Evolution of bisphosphonate-related osteonecrosis of the jaw in patients with multiple myeloma and Waldenstrom's macroglobulinemia: a retrospective multicentric study. Blood Cancer Journal 2:3, pages e62-e62.
Crossref
Crossref
Niall M.H. McLeod, Peter A. Brennan & Salvatore L. Ruggiero. (2012) Bisphosphonate osteonecrosis of the jaw: A historical and contemporary review. The Surgeon 10:1, pages 36-42.
Crossref
Crossref
Bente Thoft Jensen, Pascale Dielenseger, Lawrence Drudge-Coates, Karen Flynn, Susanne Hieronymi, H.A.M. (Erik) van Muilekom, Ronny Pieters & Lisbeth Bjerregaard Voss. (2012) Taking the lead – Sharing best practice in intravenous bisphosphonate use in urological cancers. European Journal of Oncology Nursing 16:1, pages 42-53.
Crossref
Crossref
Nobuhiro UEDA, Masaki FUJIMOTO, Yuichiro IMAI, Kumiko AOKI, Kotaro INAGAKE, Satoshi HORITA, Kazuhiko YAMAMOTO & Tadaaki KIRITA. (2012) Clinical analysis of patients treated with bisphosphonates in our clinic. Japanese Journal of Oral and Maxillofacial Surgery 58:6, pages 342-349.
Crossref
Crossref
X Ji, S Pushalkar, Y Li, R Glickman, K Fleisher & D Saxena. (2011) Antibiotic effects on bacterial profile in osteonecrosis of the jaw. Oral Diseases 18:1, pages 85-95.
Crossref
Crossref
Caterina Musolino & Alessandro Allegra. 2012. Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach. Bisphosphonates and Osteonecrosis of the Jaw: A Multidisciplinary Approach
35
48
.
John W. Hellstein, Robert A. Adler, Beatrice Edwards, Peter L. Jacobsen, John R. Kalmar, Sreenivas Koka, Cesar A. Migliorati & Helen Ristic. (2011) Managing the care of patients receiving antiresorptive therapy for prevention and treatment of osteoporosis. The Journal of the American Dental Association 142:11, pages 1243-1251.
Crossref
Crossref
P?a L?pez-Jornet, Fabio Camacho-Alonso, Ascensi?n Mart?nez-Canovas, Francisco Molina-Mi?ano, Francisco G?mez-Garc?a & Vicente Vicente-Ortega. (2011) Perioperative Antibiotic Regimen in Rats Treated With Pamidronate Plus Dexamethasone and Subjected to Dental Extraction: A Study of the Changes in the Jaws. Journal of Oral and Maxillofacial Surgery 69:10, pages 2488-2493.
Crossref
Crossref
B. Al-Nawas & K.A. Gr?tz. (2011) Risikopatienten in der zahn?rztlichen PraxisMedically compromised patients in the dental office. Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz 54:9, pages 1066-1072.
Crossref
Crossref
Teresa S. Miceli, Kathleen Colson, Beth M. Faiman, Kena Miller & Joseph D. Tariman. (2011) Maintaining Bone Health in Patients With Multiple Myeloma. Clinical Journal of Oncology Nursing 15:0, pages 9-23.
Crossref
Crossref
Peyman Hadji, Michael Gnant, Matti Aapro, Allan Lipton & Robert Coleman. (2011) Dosing of zoledronic acid throughout the treatment continuum in breast cancer. Critical Reviews in Oncology/Hematology 79:2, pages 175-188.
Crossref
Crossref
Vinod Patel, Niall M.H. McLeod, Simon N. Rogers & Peter A. Brennan. (2011) Bisphosphonate osteonecrosis of the jaw—a literature review of UK policies versus international policies on bisphosphonates, risk factors and prevention. British Journal of Oral and Maxillofacial Surgery 49:4, pages 251-257.
Crossref
Crossref
Samantha Pozzi & Noopur Raje. (2011) The Role of Bisphosphonates in Multiple Myeloma: Mechanisms, Side Effects, and the Future. The Oncologist 16:5, pages 651-662.
Crossref
Crossref
Johannes K.-H. Meier, Daniel Wolff, Steve Pavletic, Hildegard Greinix, Martin Gosau, Hartmut Bertz, Stefanie J. Lee, Ánita Lawitschka & Sharon Elad. (2010) Oral chronic graft-versus-host disease: report from the International Consensus Conference on clinical practice in cGVHD. Clinical Oral Investigations 15:2, pages 127-139.
Crossref
Crossref
Paolo Vescovi, Giuseppina Campisi, Vittorio Fusco, Giovanni Mergoni, Maddalena Manfredi, Elisabetta Merigo, Luigi Solazzo, Mario Gabriele, Giovanni M. Gaeta, Gianfranco Favia, Franco Peluso & Giuseppe Colella. (2011) Surgery-triggered and non surgery-triggered Bisphosphonate-related Osteonecrosis of the Jaws (BRONJ): A retrospective analysis of 567 cases in an Italian multicenter study. Oral Oncology 47:3, pages 191-194.
Crossref
Crossref
Sebastian Hoefert & Harald Eufinger. (2011) Relevance of a Prolonged Preoperative Antibiotic Regime in the Treatment of Bisphosphonate-Related Osteonecrosis of the Jaw. Journal of Oral and Maxillofacial Surgery 69:2, pages 362-380.
Crossref
Crossref
Evangelos Terpos, Meletios A. Dimopoulos & James Berenson. (2011) Established role of bisphosphonate therapy for prevention of skeletal complications from myeloma bone disease. Critical Reviews in Oncology/Hematology 77, pages S13-S23.
Crossref
Crossref
Gareth J Morgan, Faith E Davies, Walter M Gregory, Kim Cocks, Sue E Bell, Alex J Szubert, Nuria Navarro-Coy, Mark T Drayson, Roger G Owen, Sylvia Feyler, A John Ashcroft, Fiona Ross, Jennifer Byrne, Huw Roddie, Claudius Rudin, Gordon Cook, Graham H Jackson & J Anthony Child. (2010) First-line treatment with zoledronic acid as compared with clodronic acid in multiple myeloma (MRC Myeloma IX): a randomised controlled trial. The Lancet 376:9757, pages 1989-1999.
Crossref
Crossref
James R. Berenson. (2010) Therapeutic Options in the Management of Myeloma Bone Disease. Seminars in Oncology 37, pages S20-S29.
Crossref
Crossref
Pongthorn Narongroeknawin, Maria I. Danila, Lewis G. Humphreys Jr, Andrei Barasch & Jeffrey R. Curtis. (2010) Bisphosphonate-associated osteonecrosis of the jaw,with healing after teriparatide:a review of the literature and a case report. Special Care in Dentistry 30:2, pages 77-82.
Crossref
Crossref
Yasuyoshi Kobayashi, Toru Hiraga, Akimi Ueda, Liyang Wang, Michiyo Matsumoto-Nakano, Kenji Hata, Hirofumi Yatani & Toshiyuki Yoneda. (2009) Zoledronic acid delays wound healing of the tooth extraction socket, inhibits oral epithelial cell migration, and promotes proliferation and adhesion to hydroxyapatite of oral bacteria, without causing osteonecrosis of the jaw, in mice. Journal of Bone and Mineral Metabolism 28:2, pages 165-175.
Crossref
Crossref
Richard Oliver & Mohamed Badr. 1996. Cochrane Database of Systematic Reviews. Cochrane Database of Systematic Reviews.
Corey Langer & Vera Hirsh. (2010) Skeletal morbidity in lung cancer patients with bone metastases: Demonstrating the need for early diagnosis and treatment with bisphosphonates. Lung Cancer 67:1, pages 4-11.
Crossref
Crossref
Giovanni Lodi, Andrea Sardella, Annalisa Salis, Federica Demarosi, Marco Tarozzi & Antonio Carrassi. (2010) Tooth Extraction in Patients Taking Intravenous Bisphosphonates: A Preventive Protocol and Case Series. Journal of Oral and Maxillofacial Surgery 68:1, pages 107-110.
Crossref
Crossref
S Fedele, N Kumar, R Davies, J Fiske, S Greening & S Porter. (2009) Dental management of patients at risk of osteochemonecrosis of the jaws: a critical review. Oral Diseases 15:8, pages 527-537.
Crossref
Crossref
Kurt A. Kennel & Matthew T. Drake. (2009) Adverse Effects of Bisphosphonates: Implications for Osteoporosis Management. Mayo Clinic Proceedings 84:7, pages 632-638.
Crossref
Crossref
. (2009) Current awareness: Pharmacoepidemiology and drug safety. Pharmacoepidemiology and Drug Safety 18:5.
Crossref
Crossref